Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov

384 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov. See the species affected, top reactions, and outcomes below.

384
adverse-event reports
6.8%
death-coded share
Dog
most-reported species
151
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
384
Total Reports
26
Deaths Reported
6.8%
Death Rate

Active Ingredients

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov

Administration Routes

NasalSubcutaneousOralSubconjunctival

Species Affected

Dog 384

Most Affected Breeds

Retriever - Labrador 35
Chihuahua 29
Retriever - Golden 27
Terrier - Bull - American Pit 21
Terrier - Yorkshire 17
Shih Tzu 14
Crossbred Canine/dog 12
Bulldog - French 11
Boxer (German Boxer) 11
Spitz - German Pomeranian 10

Most Reported Reactions

Vomiting 151
Anaphylaxis 62
Lethargy (see also Central nervous system depression in 'Neurological') 54
Facial swelling (see also 'Skin') 50
Diarrhoea 43
Hives (see also 'Skin') 42
Lethargy (see also Central nervous system depression in Neurological) 41
Pale mucous membrane 39
Lack of efficacy - NOS 25
Fever 25
Decreased appetite 21
Panting 20

Outcome Breakdown

Ongoing
201 (52.3%)
Recovered/Normal
144 (37.5%)
Died
15 (3.9%)
Outcome Unknown
13 (3.4%)
Euthanized
11 (2.9%)

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov Adverse Event Insights

384 reports name Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov; 26 recorded a death outcome (6.8% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Adenov. Administration routes: Nasal, Subcutaneous, Oral, Subconjunctival.

By species: Dog (384 reports). By breed: Retriever - Labrador (35), Chihuahua (29), Retriever - Golden (27).

Leading clinical signs: Vomiting (151), Anaphylaxis (62), Lethargy (see also Central nervous system depression in 'Neurological') (54), Facial swelling (see also 'Skin') (50). Outcome, 384 coded reports: Ongoing leads at 52.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.